The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Campylobacter spp., especially Campylobacter jejuni and C. coli , are leading bacterial foodborne pathogens worldwide. In the United States, an estimated 0.8 million cases of campylobacteriosis occur annually, mostly involving C. jejuni . Campylobacteriosis is generally self-limiting, but in severe cases, treatment with antibiotics may be mandated. The increasing incidence of fluoroquinolone resistance in Campylobacter has rendered macrolides such as erythromycin and azithromycin the drugs of choice for human campylobacteriosis. The prevalence of macrolide resistance in C. jejuni remains low, but macrolide resistance can be common in C. coli . Substitutions in the 23S rRNA gene, specifically A2075G, and less frequently A2074C/G, remain the most common mechanism for high-level resistance to macrolides. In C. jejuni , resistance mediated by such substitutions is accompanied by a reduced ability to colonize chickens and other fitness costs, potentially contributing to the low incidence of macrolide resistance. Interestingly, similar fitness impacts have not been noted in C. coli . Also noteworthy is a novel mechanism first reported in 2014 for a C. coli isolate from China and mediated by erm (B) harbored on multidrug resistance genomic islands. The incidence of erm (B) appears to reflect clonal expansion of certain strains, and whole-genome sequencing has been critical to the elucidation of erm (B)-associated macrolide resistance in Campylobacter spp. With the exception of one report from Spain, erm (B)-mediated macrolide resistance has been restricted to Campylobacter spp., mostly C. coli , of animal and human origin from China. If erm (B)-mediated macrolide resistance does not confer fitness costs in C. jejuni , the range of this gene may expand in C. jejuni , threatening to compromise treatment effectiveness for severe campylobacteriosis cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657 · cited 1×
“Campylobacter jejuni is responsible for about 90% of campylobacteriosis cases, with Campylobacter coli accounting for the majority of the remainder (2, 3).”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Leclercq, R. (2002) · Clinical Infectious Diseases · doi:10.1086/324626 · Cited by 1,102
Ellington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
SCALLAN, E., HOEKSTRA, R. M., MAHON, B. E., JONES, T. F., & GRIFFIN, P. M. (2015) · Epidemiology and Infection · doi:10.1017/s0950268814003185 · Cited by 296
Cited by
Morshed, M., Lee, M.-K., Laley, J., Cook, D., Mak, A., Chahil, N., Ryan, V., Montgomery, C., Makaroff, S., Malleson, S., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00686-22 · Cited by 12
Metadata
- Authors
- Bolinger, H., & Kathariou, S.
- Venue
- Applied and Environmental Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2017-06-15
- Volume
- 83
- Issue
- 12
- ISSN
- 0099-2240 (ISSN-L)
- 1098-5336
- OpenAlex
- W2606051962
- Cited by
- 162
- References
- 5
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms. https://app.cochat.ai/papers/10.1128/aem.00416-17
- The paper
- Bolinger, H., & Kathariou, S. (2017). The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.00416-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.